Chromosome aberrations induced by clinical medicines.
暂无分享,去创建一个
F Kodama | K Fukushima | M Umeda | F. Kodama | M. Umeda | K. Fukushima
[1] T. Smitherman,et al. Methimazole: its absorption and excretion in man and tissue distribution in rats. , 1971, The Journal of clinical endocrinology and metabolism.
[2] N. Nakano. Establishment of cell lines in vitro from a mammary ascites tumor of mouse and biological properties of the established lines in a serum containing medium. , 1966, The Tohoku journal of experimental medicine.
[3] G. Moore,et al. Production of Pituitary Tumors in Mice by Chronic Administration of a Thiouracil Derivative.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[4] D. Jack,et al. The determination of hydralazine in plasma by gas-liquid chromatography. , 1975, Journal of chromatography.
[5] S. Kazmer,et al. The effect of methylxanthines on chromosomes of human lyphocytes in culture. , 1975, Mutation research.
[6] L. Cirnu-Georgian,et al. Isoniazid-induced chromosome aberrations. , 1971, Lancet.
[7] J. Willis. The induction of malignant neoplasms in the thyroid gland of the rat. , 1961, The Journal of pathology and bacteriology.
[8] J. Cabral,et al. Carcinogenicity study of rifampicin in mice and rats. , 1978, Toxicology and applied pharmacology.
[9] K. Mori,et al. Preliminary note on the induction of pulmonary tumors in mice by isonicotinic acid hydrazide feeding. , 1959, Gan.
[10] L. Severi,et al. The relation of isoniazid (INH) and allied compounds to carcinogenesis in some species of small laboratory animals: a review. , 1966, British Journal of Cancer.
[11] B. Jemec. Studies of the goitrogenic and oncogenic effect of thycapzol on C3H mice. , 1970, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[12] D. Williams,et al. CHROMOSOMES, MITOSIS, AND RESERPINE , 1975, The Lancet.
[13] K. Wasson,et al. Tuberculosis after intestinal bypass operation for obesity. , 1977, Annals of internal medicine.
[14] P. Propping,et al. Mutagenic activity of isoniazid and hydrazine in mammalian test systems. , 1972, Mutation research.
[15] P. Welling,et al. Influence of Formulation on Bioavailability Of Theophylline , 1976, Journal of clinical pharmacology.
[16] H. Lyman,et al. [12] Isolation of mutants from Euglena gracilis , 1971 .
[17] L. Georgian,et al. Cytogenetic effect of some anti-tuberculosis drugs in vitro. , 1977, Mutation research.
[18] K. Mori,et al. Induction of pulmonary tumors in mice with isonicotinic acid hydrazid. , 1960, Gan.
[19] E. C. Hammond,et al. Isoniazid therapy in relation to later occurrence of cancer in adults and in infants. , 1967, British medical journal.
[20] W. Wagner,et al. A specific assay for subannogram concentrations of reserpine in human plasma. , 1975, Life sciences.
[21] B. Tóth,et al. Lack of Carcinogenic Effects of Isonicotinic Acid Hydrazide in the Syrian Golden Hamsters , 1969, Tumori.
[22] B. Tóth,et al. Tumorigenesis with isonicotinic acid hydrazide and urethan in the Syrian golden hamsters. , 1969, European journal of cancer.
[23] J. Delâge,et al. P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy. , 1977, British Journal of Cancer.
[24] H. Marquardt. RESERPINE AND CHEMICAL CARCINOGENESIS , 1975, The Lancet.
[25] S. Greer. Growth inhibitors and their antagonists as mutagens and antimutagens in Escherichia coli. , 1958, Journal of general microbiology.